Status:
COMPLETED
Genetic Characterisation of High-grade Paediatric Osteosarcomas
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Paediatric Osteosarcomas
Eligibility:
All Genders
Up to 20 years
Brief Summary
At present, the only recognised prognostic factor for primary high-grade osteosarcoma is the histological response to preoperative chemotherapy. Our study was designed to identify new diagnostic marke...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients under 20 years of age with primary osteosarcomas
- Under treatment by the French Society of Paediatric Oncology OS 94 protocol
Exclusion
Key Trial Info
Start Date :
March 1 2003
Trial Type :
OBSERVATIONAL
End Date :
August 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00223184
Start Date
March 1 2003
End Date
August 1 2011
Last Update
August 30 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoire de Biologie Moléculaire, Hôpital de Hautepierre
Strasbourg, France, 67098
2
Service de Pédiatrie 3, Hôpital de Hautepierre
Strasbourg, France, 67098